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Introduction
The aim of this work is to develop a computational model
based on metabolic flux balancing methodology for the
primary metabolism of Streptomyces olindensis and the bio-
synthesis of cosmomycin so that metabolic shifts in
directing metabolism from growth to cosmomycin pro-
duction can be investigated.
Background
Cosmomycin, an aromatic polyketide antibiotic complex
produced by Streptomyces olindensis, belongs to anthracy-
cline family of chemotherapy drugs. It is a powerful anti-
tumor drug similar to doxorubicin and daunorubicin. The
structure of cosmomycin consists of one tetracycline agly-
con (β-rhodomycinone) and six deoxysugars (two dTDP-
L-2-deoxifucose, two dTDP-L-rodosamine and two dTDP-
L-rodinose). The tetracycline aglycon, a polyketide struc-
ture, is obtained by condensation of one propionyl-CoA
with nine acetate molecules derived from malonyl-CoA
by the action of enzymes known as minimal Polyketide
Synthetases (minimal PKS).
Model construction
The in silico metabolism was reconstructed involving more
than 240 stoichiometrically balanced metabolic reactions
in matrix formalism using the information from the liter-
ature and databases (top-down and bottom-up). Then,
computational metabolic flux balancing method was
used in order to obtain fluxes of all the metabolic reac-
tions with linear programming and optimisation in
GAMS environment (General Algebraic Modeling Sys-
tem). The objective function of optimisation was either
the maximisation of the specific growth rate or the max-
imisation of the specific cosmomycin production rate.
The experimental specific glucose uptake and growth rates
were used as the model constraints, as appropriate. The
solution of the metabolic model gave the specific growth
and/or product formation rates as well as the specific rates
of all 242 metabolic reactions.
Results
The comparison of internal metabolite fluxes between the
maximisation of specific growth and cosmomycin pro-
duction revealed important changes in fluxes related to
energy production and redox balances (NADH, FADH2,
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and ATP), as well as oxygen consumption and CO2 gener-
ation when the metabolism shifts from growth to cosmo-
mycin production. In addition, there was an important
change in the fluxes of the TCA intermediates. This indi-
cates that during growth maximisation more energy is
required, so the TCA cycle is complete, more active and
the aerobic respiration rate is increased. Another impor-
tant observation is in the acetyl-CoA flux; during growth
maximisation, this metabolite enters the TCA cycle but
during cosmomycin maximisation all acetyl-CoA goes to
malonyl-CoA, the precursor of this antibiotic. The TCA
cycle is not complete in this case and depends on the ana-
plerotic reactions and 3-phosphoglycerate. The sensitivity
analysis performed in GAMS also confirms this. This also
highlights the reason for the inclusion of casamino acids
in the culture medium in the experiments. Another
important change is observed in the glucose-1P flux
because during growth maximisation it goes to carbohy-
drate biosynthesis and during cosmomycin production it
goes to this product.
Conclusion
The results of the model and the experiments for growth
and cosmomycin production are in reasonable agreement
which means that this model can be used to identify strat-
egies for directing the metabolism from growth to second-
ary metabolism.
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